IR@PKUHSC  > 北京大学精神卫生研究所
学科主题精神卫生
The effect of risperidone treatment on superoxide dismutase in schizophrenia
Zhang, XY; Zhou, DF; Cao, LY; Zhang, PY; Wu, GY; Shen, YC
刊名JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
2003-04-01
23期:2页:128-131
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy ; Psychiatry
研究领域[WOS]Pharmacology & Pharmacy ; Psychiatry
关键词[WOS]ANTIOXIDANT DEFENSE SYSTEM ; FREE-RADICAL PATHOLOGY ; TARDIVE-DYSKINESIA ; LIPID-PEROXIDATION ; GLUTATHIONE-PEROXIDASE ; RAT-BRAIN ; ENZYMES ; HALOPERIDOL ; INPATIENTS
英文摘要

Some reports have shown that schizophrenia is accompanied by the abnormal metabolism of free radicals. The purpose of this study was to investigate the effect of the atypical antipsychotic drug risperidone on blood superoxide dismutase (SOD), a critical enzyme in the detoxification of superoxide radicals, and to explore the relationship between changes in SOD and the therapeutic outcome. Forty-one inpatients with diagnosed schizophrenia (DSM-III-R) were assigned to 12 weeks of treatment with risperidone at a fixed dosage of 6 mg/d after a 2-week washout period. Clinical efficacy was determined with the Positive and Negative Syndrome Scale (PANSS). Blood SOD was assayed by radioimmunoassay (RIA) in schizophrenic patients before and after the 12-week treatment, and the values were compared with those of 50 age-, sex-, and smoking-matched subjects without schizophrenia. Risperidone treatment significantly decreased the initially high blood SOD levels in schizophrenia. There was a significantly positive relationship between the change in SOD at pretreatment and posttreatment and the reduction in the PANSS negative subscore. These findings suggest that risperidone treatment significantly decreased the blood SOD levels of schizophrenic patients, a change which may be associated with the diminishment of symptoms. The limitations of this study are the measurement of SOD levels by RIA rather than biochemical assay; the 2-week washout, which may not be adequate; and the measurement of only SOD enzyme and not the other antioxidant enzymes.

语种英语
WOS记录号WOS:000181809500004
引用统计
被引频次:41[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65901
专题北京大学精神卫生研究所
作者单位1.Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China
2.Beijing Huilongguan Hosp, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Zhang, XY,Zhou, DF,Cao, LY,et al. The effect of risperidone treatment on superoxide dismutase in schizophrenia[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY,2003,23(2):128-131.
APA Zhang, XY,Zhou, DF,Cao, LY,Zhang, PY,Wu, GY,&Shen, YC.(2003).The effect of risperidone treatment on superoxide dismutase in schizophrenia.JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY,23(2),128-131.
MLA Zhang, XY,et al."The effect of risperidone treatment on superoxide dismutase in schizophrenia".JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 23.2(2003):128-131.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, XY]的文章
[Zhou, DF]的文章
[Cao, LY]的文章
百度学术
百度学术中相似的文章
[Zhang, XY]的文章
[Zhou, DF]的文章
[Cao, LY]的文章
必应学术
必应学术中相似的文章
[Zhang, XY]的文章
[Zhou, DF]的文章
[Cao, LY]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。